These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28383112)

  • 1. Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.
    Binder M; O'Byrne MM; Maurer MJ; Ansell S; Feldman AL; Cerhan J; Novak A; Porrata LF; Markovic S; Link BK; Witzig TE
    Am J Hematol; 2017 Aug; 92(8):752-758. PubMed ID: 28383112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
    Li C; Li W; Xu G; You M; Wu W; Kuang L
    Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
    Br J Haematol; 2012 May; 157(3):321-30. PubMed ID: 22360654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.
    Porrata LF; Ristow KM; Habermann TM; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski G; Thompson CA; Markovic SN
    Leuk Lymphoma; 2014 Dec; 55(12):2728-38. PubMed ID: 24547705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
    Yan-Li L; Kang-Sheng G; Yue-Yin P; Yang J; Zhi-Min Z
    Leuk Res; 2014 Mar; 38(3):323-8. PubMed ID: 24439567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
    Vassilakopoulos TP; Dimopoulou MN; Angelopoulou MK; Petevi K; Pangalis GA; Moschogiannis M; Dimou M; Boutsikas G; Kanellopoulos A; Gainaru G; Plata E; Flevari P; Koutsi K; Papageorgiou L; Telonis V; Tsaftaridis P; Sachanas S; Yiakoumis X; Tsirkinidis P; Viniou NA; Siakantaris MP; Variami E; Kyrtsonis MC; Meletis J; Panayiotidis P; Konstantopoulos K
    Oncologist; 2016 Mar; 21(3):343-53. PubMed ID: 26921291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.
    Kumagai S; Tashima M; Fujikawa J; Iwasaki M; Iwamoto Y; Sueki Y; Fukunaga A; Yanagita S; Nishikori M; Takaori-Kondo A; Arima N
    Int J Hematol; 2014 Jun; 99(6):737-42. PubMed ID: 24756873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
    Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
    Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma.
    Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B
    Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
    Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
    Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
    Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
    Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era.
    Aoki K; Tabata S; Yonetani N; Matsushita A; Ishikawa T
    Acta Haematol; 2013; 130(4):242-6. PubMed ID: 23860478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
    Chen Y; Neelapu S; Feng L; Bi W; Yang TH; Wang M; Fanale MA; Westin JR; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Fowler NH; McLaughlin P; Cabanillas F; Oki Y; Nastoupil LJ; Rodriguez A
    Br J Haematol; 2016 Oct; 175(2):290-299. PubMed ID: 27448187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ALC/AMC Value and Prognosis in Patients with Primary Follicular Lymphoma Treated with R-CHOP Chemotherapy].
    Cui Y; Shi P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):177-181. PubMed ID: 29397839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma.
    Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
    Anticancer Res; 2014 Sep; 34(9):5163-8. PubMed ID: 25202109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma.
    Mohsen A; Taalab M; Abousamra N; Mabed M
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e606-e615. PubMed ID: 32303487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
    Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
    Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens.
    Li YL; Pan YY; Jiao Y; Ning J; Fan YG; Zhai ZM
    Ann Hematol; 2014 Apr; 93(4):617-26. PubMed ID: 24141331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
    Porrata LF; Ristow KM; Habermann TM; Macon WR; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski G; Thompson CA; Markovic SN
    Blood Cancer J; 2013 Apr; 3(4):e110. PubMed ID: 23599022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
    Li YL; Gu KS; Pan YY; Jiao Y; Zhai ZM
    BMC Cancer; 2014 May; 14():341. PubMed ID: 24884604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.